ReviewMaterials (Basel, Switzerland)2026
Bioactive Fillers in Bulk-Fill Composite Resins: A Comprehensive Review of the Effects on Polymerization Shrinkage Behavior and Mechanical Performance.
Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymerization shrinkage remains a primary cause of marginal failure in posterior composite restorations, contributing to interfacial gap formation and secondary caries development. Bioactive filler technologies represent a paradigm shift, offering simultaneous stress reduction and therapeutic ion release through engineered matrix-filler interactions. This narrative review synthesizes current evidence on how bioactive glass (including 45S5), amorphous calcium phosphate, and surface pre-reacted glass-ionomer fillers modulate polymerization shrinkage dynamics and mechanical performance in bulk-fill systems. These systems exhibit distinct mechanisms of bioactivity, with bioactive glass (45S5) promoting ion release and apatite formation, amorphous calcium phosphate (ACP) enabling rapid calcium phosphate ion delivery for remineralization, and surface pre-reacted glass-ionomer (S-PRG) fillers providing sustained multi-ion release with buffering and antibacterial potential. A comprehensive literature search was conducted in PubMed/MEDLINE, Scopus, and Web of Science for studies published up to June 2025, including experimental investigations and reviews assessing bioactive filler integration, with studies selected based on predefined inclusion and exclusion criteria focusing on relevance and reported outcomes. The available evidence indicates that optimized bioactive formulations reduce shrinkage stress by approximately 25-40%, decreasing from 35-40 MPa in conventional systems to 22-32 MPa in bioactive bulk-fill composites while maintaining flexural strength above 100 MPa and elastic modulus within clinically acceptable ranges (11-13 GPa). However, substantial heterogeneity in filler chemistry, loading protocols, and testing methodologies limits cross-study comparisons. This variability also reflects differences in testing conditions, material compositions, and evaluation protocols across studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.